Skip Navigation Links.
Collapse <span class="m110 colortj mt20 fontw700">Volume 12 (2024)</span>Volume 12 (2024)
Collapse <span class="m110 colortj mt20 fontw700">Volume 11 (2023)</span>Volume 11 (2023)
Collapse <span class="m110 colortj mt20 fontw700">Volume 10 (2022)</span>Volume 10 (2022)
Collapse <span class="m110 colortj mt20 fontw700">Volume 9 (2021)</span>Volume 9 (2021)
Collapse <span class="m110 colortj mt20 fontw700">Volume 8 (2020)</span>Volume 8 (2020)
Collapse <span class="m110 colortj mt20 fontw700">Volume 7 (2019)</span>Volume 7 (2019)
Collapse <span class="m110 colortj mt20 fontw700">Volume 6 (2018)</span>Volume 6 (2018)
Collapse <span class="m110 colortj mt20 fontw700">Volume 5 (2017)</span>Volume 5 (2017)
Collapse <span class="m110 colortj mt20 fontw700">Volume 4 (2016)</span>Volume 4 (2016)
Collapse <span class="m110 colortj mt20 fontw700">Volume 3 (2015)</span>Volume 3 (2015)
Collapse <span class="m110 colortj mt20 fontw700">Volume 2 (2014)</span>Volume 2 (2014)
Collapse <span class="m110 colortj mt20 fontw700">Volume 1 (2013)</span>Volume 1 (2013)
American Journal of Medical Case Reports. 2019, 7(6), 117-120
DOI: 10.12691/AJMCR-7-6-5
Case Report

Rare Case of Rectal Mixed Adeno-Neuroendocrine Carcinoma

Aleksander Khudiakov1, Mohammed Al-Sadawi1, Jia Qin1, Michael Haddadin1, Stanley Soroka1, Angeleque Hartt1, Lina Soni1, Shalini Arora2 and Samy I. McFarlane1,

1Department of Internal Medicine, State University of New York: Downstate Medical Center, Brooklyn, New York, United States- 11203

2Department of Endocrine Surgery, Kings County Hospital Center, Brooklyn, NY 11203

Pub. Date: June 12, 2019
Full Text PDF

Cite this paper

Aleksander Khudiakov, Mohammed Al-Sadawi, Jia Qin, Michael Haddadin, Stanley Soroka, Angeleque Hartt, Lina Soni, Shalini Arora and Samy I. McFarlane. Rare Case of Rectal Mixed Adeno-Neuroendocrine Carcinoma. American Journal of Medical Case Reports. 2019; 7(6):117-120. doi: 10.12691/AJMCR-7-6-5

Abstract

Colorectal cancer is the third most common cancer in both men and women. Mixed adenoneuroendocrine carcinoma is a rare subtype of colorectal cancer defined as malignant neoplasms in which each component represents at least 30% of the lesion. It was named as Mixed adenoneuroendocrine carcinoma and described by the World Health Organization in 2010. Due to its morphological heterogeneity and the rarity of the condition, it becomes quite challenging to formulate an appropriate treatment plan. In this report, we present a case of 67-year-old man found to have a rectal mixed adenoneuroendocrine carcinoma. We discussed the current management strategies and provide a review of the literature.

Keywords

adeno-neuroendocrine carcinoma

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1; 136(5): E359-86.
 
[2]  Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014 Apr 26; 383(9927):1490-1502.
 
[3]  Bosman FT, Carneiro F, Hruban RH, THeise ND, eds. WHO Classification of Tumours of the Digestive System, 4th Edition. IARC Press, Lyon, 2010 pp. 13-4.
 
[4]  Düzköylü Y, Aras O, Bostancı EB, Temuçin TK, Ulaş M. Mixed Adeno-Neuroendocrine Carcinoma; Case Series of Ten Patients with Review of the Literature. Balkan Med J. 2018 May; 35(3): 263-267.
 
[5]  Jesinghaus M, Konukiewitz B, Keller G, Kloor M, Steiger K, Reiche M, et al. Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas. Mod Pathol. 2017 Apr; 30(4):610-619.
 
[6]  Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012 Jun; 10(6): 639-45.
 
[7]  Cordier R. Les cellules argentaffines dans les tumeurs intestinales. Arch. Int. Med. Exp. 1924; 1: 5.
 
[8]  Rindi G., Arnold R., Bosman F.T., Capella C., Kilmstra D.S., Kloppel G., Komminoth P., Solcia E. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman F.T., Carneiro F., Hruban R.H., Theise N.D., editors. WHO Classification of Tumours of the Digestive System. 4th. IARC Press; Lyon, France: 2010. pp. 13-14.
 
[9]  La Rosa S, Marando A, Furlan D, Sahnane N, Capella C. Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers. Am J Surg Pathol. 2012 Apr; 36(4): 601-11.
 
[10]  Klimstra DS, Modlin IR, Adsay NV, et al. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol. 2010; 34(3): 300-313.
 
[11]  La Rosa S, Marando A, Sessa F, Capella C. Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update. Cancers (Basel). 2012;4 (1): 11-30. Published 2012 Jan 16.
 
[12]  Hervieu V, Scoazec JY. [Mixed endocrine tumors]. Ann Pathol. 2005 Dec; 25(6): 511-28.
 
[13]  Maru DM, Khurana H, Rashid A, Correa AM, Anandasabapathy S, Krishnan S, Komaki R, Ajani JA, Swisher SG, Hofstetter WL. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol. 2008 Sep; 32(9): 1404-11.